MyFinsight
Home
Blog
About
Contact
Proceeds from exercise of
options
$6,403K
Net cash provided by
financing activities
$6,403K
Net (decrease)
increase in cash and cash...
-$147,899K
Canceled cashflow
$6,403K
Sale of marketable
securities- available for...
$376,359K
Sale of marketable
securities- equity...
$9,885K
Non-cash interest
expense on liability...
$65,699K
Share-based compensation
expense
$23,421K
Depreciation and
amortization
$15,413K
Inventory, net
-$2,643K
Non-cash operating lease
expense
$1,761K
Prepaid expenses and
other current assets
-$1,180K
Tangible asset
impairment and losses on...
-$927K
Amortization of debt issuance
costs
$305K
Net cash used in
investing activities
-$93,736K
Net cash (used in)
provided by operating...
-$59,042K
Canceled cashflow
$386,244K
Canceled cashflow
$111,349K
Effect of exchange rate
changes on cash
-$1,524K
Total revenues
$272,551K
Purchases of marketable
securities- available for...
$454,670K
Accounts payable and
accrued expenses
-$68,713K
Purchases of marketable
securities- equity...
$23,957K
Purchases of fixed assets
$1,197K
Acquisition of product
rights and licenses
$156K
Non-cash royalty revenue
related to sale of future...
$46,835K
Trade and royalty
receivables, net
$40,390K
Amortization of discounts on
investments, net
$4,114K
Net (loss) income
-$2,809K
Other liabilities
-$2,309K
Deposits and other assets
$1,588K
Deferred revenue
-$1,522K
Unrealized gain on
marketable securities -...
$1,214K
Unrealized foreign
currency transaction...
$887K
Deferred income taxes
-$10K
Canceled cashflow
$272,551K
Total other segment
items
$107,889K
Employee costs
$76,121K
Program spend
$37,544K
Cost of product,
collaboration and license...
$19,679K
Administrative costs
$16,688K
Manufacturing costs
$9,085K
Occupancy costs
$8,354K
Back
Back
Cash Flow
PTC THERAPEUTICS, INC. (PTCT)
PTC THERAPEUTICS, INC. (PTCT)
source: myfinsight.com